Mirus Bio LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mirus Bio LLC - overview
Established
1995
Location
Madison, WI, US
Primary Industry
Biotechnology
About
Based in Wisconsin, US, and founded by Jon Wolff, James Hagstrom, and Vladimir Budker in 1995, Mirus Bio LLC is a biotechnological research company that produces transfection reagents with the use of non-viral gene delivery processes. In May 2021, Gamma Biosciences GP LLC, a portfolio company of KKR, acquired a majority stake in Mirus Bio LLC. The company investigates nucleic acid delivery to provide tools for gene expression, biotherapeutic protein production, virus manufacturing, and genome editing to life scientists. The firm’s research products also include AAV production, antibiotics, CRISPR, DNA transfection, electroporation, endotoxin removal, in-vivo delivery, labeling, etc.
Current Investors
Gamma Biosciences GP LLC
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.mirusbio.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Mirus Bio LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Mirus Bio LLC | - | ||||||||
| Add-on | Completed | Mirus Bio LLC | - |
Displaying 1 - 2 of 2
Mirus Bio LLC - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.